Accurate Mycoplasma testing safeguards the integrity of biologics and advanced therapies. Undetected contamination can lead to batch failure, regulatory non-compliance, and significant financial loss. Implementing sensitive, rapid detection methods ensures product consistency, safety, and GMP-level quality assurance. https://beforeitsnews.com/healthcare/2025/12/new-advances-in-mycoplasma-detection-strengthen-safety-standards-across-biopharmaceutical-manufacturing-2-2543610.html